Building bone to reverse osteoporosis and repair fractures - Wikidata - wikimedia - TriplyDB

Building bone to reverse osteoporosis and repair fractures

Building bone to reverse osteoporosis and repair fractures

http://www.wikidata.org/entity/Q36407024

about

Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation Fracture healing: mechanisms and interventions Repression of osteoblast maturation by ERRα accounts for bone loss induced by estrogen deficiency Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat Increasing options for the treatment of osteoporosis Akt promotes BMP2-mediated osteoblast differentiation and bone development Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities Premature osteoblast clustering by enamel matrix proteins induces osteoblast differentiation through up-regulation of connexin 43 and N-cadherin Nanoscale X-ray microscopic imaging of mammalian mineralized tissue.Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs.Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation.Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.Runx2 trans-activation mediated by the MSX2-interacting nuclear target requires homeodomain interacting protein kinase-3.Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations.Update on estrogens and the skeleton The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro.Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB.Emerging therapeutic opportunities for skeletal restoration.Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.A paradigm for the development and evaluation of novel implant topologies for bone fixation: in vivo evaluation.Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formation Single bout short duration fluid shear stress induces osteogenic differentiation of MC3T3-E1 cells via integrin β1 and BMP2 signaling cross-talk.Altered microRNA expression profile in exosomes during osteogenic differentiation of human bone marrow-derived mesenchymal stem cells Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion.Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass.The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women.Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice The orphan nuclear receptor SHP is a positive regulator of osteoblastic bone formation.Strategies of spinal fusion on osteoporotic spine.A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia The impact of vitamin D status on periodontal surgery outcomes.The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

P2860

Q24635851-FF583630-61A5-478D-8FD2-F56F4D4B2ED2 Q26851958-95A9FC3A-4459-4C28-90ED-C5F20A414F40 Q27318225-658D6117-131F-4E12-A401-683C56D54382 Q27324052-9B347C86-BE70-4E2C-91E0-A018BF8582CD Q28254516-1E1954A0-10F0-4E07-8371-A840F4ED43DA Q28511143-FCC13AAA-4F97-4619-9D59-F41AC726707D Q28728315-6660699C-F812-4EBA-9D36-D45E74C6EEAF Q28741433-530A21CA-D7C3-4C33-A952-153D711304BA Q30494597-26803F2B-A5B8-4BE7-974D-5BAC2185BABF Q33555616-7053A35D-5AE4-4740-B2E3-6893CB8FB761 Q33627269-7D80EB70-FE6F-4705-90EA-4AA15D04E8C7 Q33749859-163E9307-98FF-4EE9-B31F-82E96B39227C Q33993675-2A2DA603-F02F-49CB-8C2E-3AD5198E066F Q34024085-F48B9DE9-D3E4-4243-9D03-E6884915C8FC Q34031994-3DD0BDD4-5FEF-455B-909C-D1B5789F5356 Q34039646-B59B8EBC-7113-4143-A147-93A41BABECAB Q34156626-40ECAD6B-89FD-482D-BACC-CC2CC9EEC527 Q34161867-F3336FCA-F374-4B95-9E21-D84618AF9D22 Q34262453-1E6DAD1E-0BC4-4EFF-9128-E11D4ED5F80B Q34286052-EDB28002-72AB-42AD-BBAC-CFB4C07726AA Q34362253-C4E588CF-0F64-4AC2-A89A-DDCCD9EEE7AB Q34404255-49D77CAD-4C4C-4CFD-B495-7C464491579B Q34567531-DAEB0B16-C1F5-42CF-9FC5-663B293E6D6D Q34675005-F4335475-3CA3-453D-8EB4-68AA81823F35 Q34682095-35841E6A-F7F7-47A8-9E75-C9F446BC61C5 Q34719382-B6FFFFC6-7A85-49EB-BAB3-417ACED72EF7 Q35001021-103EEB2A-1D6A-4C49-90B6-18318F5041DE Q35007314-D4FAFDEF-191E-4517-B09B-CFBDFCD8FF97 Q35080134-96F601CB-8805-458A-8DE9-54A2B0204DD4 Q35087758-22D8CECE-A0EA-4C6A-B2BA-AD17970C76A6 Q35127168-6FBCD702-882F-4103-81A0-F4AC32C63952 Q35156214-603B2495-CC5F-4E75-8840-092183DDCD15 Q35156238-B37EC8A9-3EAC-4772-ABFB-C57B7C6F073C Q35171786-7C5F48A1-C84A-40FA-905B-A617C5B1CAFB Q35196329-5B6FF83B-B49E-4599-AD23-E33B66C92490 Q35206006-CF61B6A5-2213-41F1-8DF9-28D2FA6DF2F5 Q35229894-2C047E82-E955-4CAB-9205-1862E0818504 Q35357373-3962A97F-8233-4937-BAB9-9CBB23B4193C Q35486453-F6B774CE-8EB4-47C1-BE9E-2AF4269EA88C Q35665655-2120016E-01D5-427C-AADE-219B6CD522A6

P2860

Building bone to reverse osteoporosis and repair fractures

http://www.wikidata.org/entity/Q36407024

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Building bone to reverse osteoporosis and repair fractures

@ast

Building bone to reverse osteoporosis and repair fractures

@en

type

label

Building bone to reverse osteoporosis and repair fractures

@ast

Building bone to reverse osteoporosis and repair fractures

@en

prefLabel

Building bone to reverse osteoporosis and repair fractures

@ast

Building bone to reverse osteoporosis and repair fractures

@en

P1433

Q36407024-FC3FBDE4-E364-4B31-9C0F-FA716EFBB49F

P1476

Q36407024-EE86AB2B-76C3-4B5F-B798-C126E8DA5494

P2093

Q36407024-73B977A1-52C8-4171-8BE4-723E003106A9

Q36407024-7DF2A5FE-419C-487D-B140-165D6BA6A567

Q36407024-B4E53C3D-811E-4DA0-83AA-155C77640B14

P2860

Q36407024-00724C89-54D8-4335-9C30-D6A620BA7F38

Q36407024-0133A2C0-0194-408E-B739-6DC775F8E48C

Q36407024-024BB3BB-2B15-468E-961F-C110F5A8BBBB

Q36407024-03FE4E49-A951-480A-9694-79AAA74CBF4F

Q36407024-08D19B96-A986-4E7E-BEC4-936AC9D60065

Q36407024-098D94D9-C5E7-4CDE-BB44-7DD569D599A6

Q36407024-0BFA172D-BFB1-4879-A480-A8699BCCD9A9

Q36407024-175AC4F0-7A74-4750-B189-5FDF8AE153DE

Q36407024-1B889C51-87A9-4923-A160-29845966EF3E

Q36407024-1C92D36E-CC83-4373-B426-A5DCE1D7CE8E

P304

Q36407024-682F7AD8-A0DD-4A2C-B732-6C7881478695

P31

Q36407024-6E9F8212-3B72-4DFB-B69C-6B27750F2292

P356

Q36407024-A5128094-87B1-476F-936E-F12005B6699F

P407

Q36407024-538BB879-D132-4E6F-8E95-100BC627A067

P433

Q36407024-0950A0E6-C596-481D-ADCA-B007C9AA18CF

P478

Q36407024-1095E841-1AAF-46A4-9D88-62A867F0766F

P577

Q36407024-A117C01B-21FC-4A3C-A0D8-DD0040D41CD3

P5875

Q36407024-FF071BE5-5A62-4588-A128-56D0E8AA8B5F

P698

Q36407024-993D3FDB-1C6D-4DA4-BDE6-65B217C76D13

P921

Q36407024-2B0CE1BB-D0E7-4277-BE2D-8DB0EDA75E3C

P932

Q36407024-E6102CF4-6230-4D27-974F-8A40B65E66C5

P356

P1433

Journal of Clinical Investigation

P1476

Building bone to reverse osteoporosis and repair fractures

@en

P2093

Jennifer J Westendorf

http://www.w3.org/2001/XMLSchema#string

Merry Jo Oursler

http://www.w3.org/2001/XMLSchema#string

Sundeep Khosla

http://www.w3.org/2001/XMLSchema#string

P2860

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing

P304

421-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI33612

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5606395

http://www.w3.org/2001/XMLSchema#string

P698

18246192

http://www.w3.org/2001/XMLSchema#string

P921

P932

2214701

http://www.w3.org/2001/XMLSchema#string